Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Nakanishi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cureus|December 2, 2024
Influenza A Infection With Virus-Associated Pneumonia and Hemorrhagic Shock and Encephalopathy Syndrome in an AdultYu Nakanishi, Noriko Tanimoto, Mako Tsuyuki, et al.
Internal Medicine (Tokyo, Japan)|December 10, 2025
New-onset anti-melanoma differentiation-associated gene 5 antibody positive clinically amyopathic dermatomyositis following COVID-19: A case reportYu Nakanishi, Hirofumi Watanabe, Mako Tsuyuki, et al.
Plos Biology|August 31, 2023
An interactive deep learning-based approach reveals mitochondrial cristae topologiesShogo Suga, Koki Nakamura, Yu Nakanishi, et al.
Internal Medicine (Tokyo, Japan)|November 10, 2024
Anti-OJ Antibody-positive Antisynthetase Myopathy Diagnosed after Pulmonary EmbolizationYu Nakanishi, Hirofumi Watanabe, Yoshihiro Tsuyuki, et al.
Internal Medicine (Tokyo, Japan)|August 20, 2025
Allergic Bronchopulmonary Mycosis Caused by Nigroporus vinosus: A Case ReportYu Nakanishi, Takashi Saito, Shoshi Akieda, et al.
Plos One|June 4, 2021
IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosisYu Nakanishi, Yasushi Horimasu, Kakuhiro Yamaguchi, et al.
Respiratory Investigation|June 29, 2019
Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancerYu Nakanishi, Takeshi Masuda, Kakuhiro Yamaguchi, et al.
Internal Medicine (Tokyo, Japan)|June 26, 2020
Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive DermatomyositisYu Nakanishi, Kakuhiro Yamaguchi, Yusuke Yoshida, et al.
International Journal of Clinical Oncology|September 19, 2019
Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancerYu Nakanishi, Takeshi Masuda, Kakuhiro Yamaguchi, et al.
Journal of Asthma and Allergy|November 1, 2022
Association Between Patient Preference for Inhaler Medications and Asthma OutcomesYu Nakanishi, Hiroshi Iwamoto, Shintaro Miyamoto, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cureus|December 2, 2024
Influenza A Infection With Virus-Associated Pneumonia and Hemorrhagic Shock and Encephalopathy Syndrome in an AdultYu Nakanishi, Noriko Tanimoto, Mako Tsuyuki, et al.
Internal Medicine (Tokyo, Japan)|December 10, 2025
New-onset anti-melanoma differentiation-associated gene 5 antibody positive clinically amyopathic dermatomyositis following COVID-19: A case reportYu Nakanishi, Hirofumi Watanabe, Mako Tsuyuki, et al.
Plos Biology|August 31, 2023
An interactive deep learning-based approach reveals mitochondrial cristae topologiesShogo Suga, Koki Nakamura, Yu Nakanishi, et al.
Internal Medicine (Tokyo, Japan)|November 10, 2024
Anti-OJ Antibody-positive Antisynthetase Myopathy Diagnosed after Pulmonary EmbolizationYu Nakanishi, Hirofumi Watanabe, Yoshihiro Tsuyuki, et al.
Internal Medicine (Tokyo, Japan)|August 20, 2025
Allergic Bronchopulmonary Mycosis Caused by Nigroporus vinosus: A Case ReportYu Nakanishi, Takashi Saito, Shoshi Akieda, et al.
Plos One|June 4, 2021
IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosisYu Nakanishi, Yasushi Horimasu, Kakuhiro Yamaguchi, et al.
Respiratory Investigation|June 29, 2019
Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancerYu Nakanishi, Takeshi Masuda, Kakuhiro Yamaguchi, et al.
Internal Medicine (Tokyo, Japan)|June 26, 2020
Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive DermatomyositisYu Nakanishi, Kakuhiro Yamaguchi, Yusuke Yoshida, et al.
International Journal of Clinical Oncology|September 19, 2019
Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancerYu Nakanishi, Takeshi Masuda, Kakuhiro Yamaguchi, et al.
Journal of Asthma and Allergy|November 1, 2022
Association Between Patient Preference for Inhaler Medications and Asthma OutcomesYu Nakanishi, Hiroshi Iwamoto, Shintaro Miyamoto, et al.
Pageof 1